It has, however, already been shown that lowering uric acid with the xanthine oxidase inhibitor (XOI) allopurinol improved insulin resistance and systemic inflammation in asymptomatic hyperuricemia in a randomized controlled trial almost ten years ago [49]. This evidence concerns the gene XDH and hyperuricemia.